The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Development of CBT for chemotherapy‐related cognitive change: results of a waitlist control trial
Open accessAbstract
Objective: To evaluate the efficacy of a brief cognitive‐behavioral therapy (CBT) that is being developed for management of cognitive dysfunction following chemotherapy among breast cancer survivors. Memory and Attention Adaptation Training (MAAT) is a brief CBT designed to improve the quality of life and function among cancer survivors with post‐chemotherapy cognitive complaints. Methods: An initial, two‐group (MAAT versus waitlist, no treatment control), randomized clinical trial (RCT) was conducted. Forty stage I and II female breast cancer survivors (mean age = 50; SD = 6.4) were randomized to conditions and assessed at baseline, post‐treatment (8 weeks) and 2‐month follow‐up assessment points on measures of: (1) self‐reported daily cognitive failures; (2) quality of life; and (3) neuropsychological performance. Participants were also assessed for satisfaction with MAAT. Results: With education and IQ as covariates, MAAT participants made significant improvements relative to controls on the spiritual well‐being subscale of the quality of life measure and on verbal memory, but statistical significance was not achieved on self‐report of daily cognitive complaints. However, moderate‐to‐large effect sizes were observed on these outcomes. Participants gave MAAT high satisfaction ratings. Conclusions: Although this initial RCT is a small study, MAAT participants appear to improve on one measure of quality of life and verbal memory performance relative to no treatment controls and rate MAAT with high satisfaction. These data are encouraging and support the continued development and evaluation of MAAT efficacy.Copyright © 2010 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cohen, J. (1992) · Current Directions in Psychological Science · doi:10.1111/1467-8721.ep10768783 · Cited by 5,870
Hoffman, S. G., & Smits, J. A. J. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0415 · Cited by 1,420 · cited 1×
“5% (5 of 40 participants), which is an improvement over a 19% attrition rate in previous MAAT research [16] and is better than an average 23% attrition rate of CBT trials in anxiety disorders research [45].”
Measurement of the quality of life in cancer survivors
Ferrell, B. R., Hassey Dow, K., & Grant, M. (1995) · Quality of Life Research · doi:10.1007/bf00634747 · Cited by 689
Attrition in longitudinal studies
Twisk, J., & de Vente, W. (2002) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(01)00476-0 · Cited by 527 · cited 1×
“Amore complete discussion can be seen by Twisk [53].”
Background
Research works printed but not linked: 54
- 10.1093/annonc/mdm500 · DOI · Paper page
- 10.1007/s11910-003-0081-2 · DOI
- 10.1200/JCO.2004.08.094 · DOI · Paper page
- 10.1200/JCO.2006.08.1604 · DOI · Paper page
- 10.1200/JCO.2000.18.14.2695 · DOI · Paper page
- 10.1080/14733400410001727583 · doi:10.1080/14733400410001727583
- Schagen S, 2006, Change in Cognitive Function After Chemotherapy: A Prospective Longitudinal Study in Breast Cancer Patients, © The Author 2006, 1742
- 10.1081/CNV-100107743 · DOI · Paper page
- 10.1200/JCO.2004.08.094 · DOI · Paper page
- 10.1038/nrc2073 · DOI · Paper page
- 10.1200/JCO.2007.10.8639 · DOI · Paper page
- 10.1007/s10549-006-9380-z · DOI · Paper page
- 10.1016/j.bbr.2007.04.003 · DOI
- 10.1200/JCO.2005.03.343 · DOI
- Vardy J, 2009, Cognitive function in survivors of cancer, Am Soc Clin Oncol Educational Book, 2009, 570
- 10.1002/pon.1133 · DOI · Paper page
- Reuben S, President's Cancer Panel 2003/2004
- 10.1007/s10552-005-0452-x · DOI
- Lower E, 2005, A phase III, randomized placebo‐controlled trial of the saftey adn efficcy of d‐mph as new treatment of fatigue and ‘emobrain’ in adult cancer patients, J Clin Oncol, 23, 729s
- Kohli S, 2007, The cognitive effects of modafinil in breast cancer survivors: a randomized clinical trail, J Clin Oncol, 25, 9004, 10.1200/jco.2007.25.18_suppl.9004 · DOI
- 10.1023/A:1026464827874 · DOI
- 10.1146/annurev.clinpsy.4.022007.141212 · DOI · Paper page
- 10.1037/a0013659 · DOI · Paper page
- 10.1007/s11065-009-9119-9 · DOI · Paper page
- Wagner LI, 2003, Chemotherapy‐related cognitive deficits: a qualitative examination of patients and providers, Ann Behav Med, 25, S056
- Vardy J, 2008, Relation between perceived cognitive function and neuropsychological performance in survivors of breast and colorectal, Cancer, 26, 9520
- 10.1001/jama.1994.03520220043029 · DOI · Paper page
- 10.1002/cncr.21482 · DOI
- Fan H, 2006, Does cognitive impairment after chemotherapy for breast cancer improve over time or does practice make perfect?, J Clin Oncol, 24, 5171
- 10.1002/cncr.24192 · DOI
- MeichenbaumD AsarnowJ.Cognitive‐behavioral modification and metacognitive development: implications for the classroom. Cognitive‐behavioral interventions: Theory research and procedures1979;1–35. · DOI · Paper page
- 10.1080/01688639408402620 · DOI · Paper page
- 10.1007/BF01806154 · DOI · Paper page
- 10.1177/014662167700100306 · DOI · Paper page
- 10.1016/S0022-3999(99)00004-5 · DOI · Paper page
- Spielberger C, 1977, Stai Manual
- 10.1200/JCO.2002.20.2.485 · DOI · Paper page
- Delis D, 2000, CVLT‐II, California Verbal Learning Test, Adult Version, Manual
- Delis D, 2001, D‐kefs Executive Function System Examiner's Manual
- Wechsler D., 1997, Wechsler Adult Intelligence Scale‐III (WAIS‐III)
- De Vaus D., 2002, Analyzing Social Science Data: 50 Key Problems in Data Analysis
- 10.1037/0022-006X.52.5.885 · doi:10.1037/0022-006x.52.5.885 · Paper page
- 10.1037/0022-006X.76.3.367 · DOI · Paper page
- 10.1007/s11910-003-0081-2 · DOI
- 10.1007/s11065-008-9058-x · DOI
- WagnerL LaiJ CellaD SweetJ ForrestalS.Chemotherapy‐related cognitive deficits: development of the fact‐cog instrument. Poster Presented at the 25th Annual Scientific Session of the Society of Behavioral Medicine Baltimore Maryland. Abstract: Annals of Behavioral Medicine2004;27.
- 10.1007/s10549-007-9686-5 · DOI · Paper page
- 10.1037/0022-006X.76.3.367 · DOI · Paper page
- 10.1037/10693-000 · DOI · Paper page
- Feuerstein M., 2006, Handbook of Cancer Survivorship
- Snijders T, 1999, Multilevel Analysis: An Introduction to Basic and Advanced Multilevel Modeling
- 10.1007/s00520-006-0037-6 · DOI
- WagnerL.Fact‐cog version 3 psychometric properties. ICCTF Workshop: Measuring Perceived Cognitive Function October 2008 Venice.
- 10.1200/JCO.2009.27.0827 · DOI · Paper page
Cited by
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
Distress Management, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology
Riba, M. B., Donovan, K. A., Andersen, B., Braun, I., Breitbart, W. S., Brewer, B. W., Buchmann, L. O., Clark, M. M., Collins, M., Corbett, C., et al. (2019) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2019.0048 · Cited by 871
Prevalence, mechanisms, and management of cancer-related cognitive impairment
Janelsins, M. C., Kesler, S. R., Ahles, T. A., & Morrow, G. R. (2014) · International Review of Psychiatry · doi:10.3109/09540261.2013.864260 · Cited by 745
Self-citationCancer- and Cancer Treatment–Associated Cognitive Change: An Update on the State of the Science
Ahles, T. A., Root, J. C., & Ryan, E. L. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.43.0116 · Cited by 704
Self-citationWefel, J. S., Kesler, S. R., Noll, K. R., & Schagen, S. B. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21258 · Cited by 532
Metadata
- Authors
- Ferguson, R. J., McDonald, B. C., Rocque, M. A., Furstenberg, C. T., Horrigan, S., Ahles, T. A., & Saykin, A. J.
- Venue
- Psycho-Oncology
- Publisher
- Wiley
- Published
- 2010-12-02
- Volume
- 21
- Issue
- 2
- Pages
- 176-186
- ISSN
- 1057-9249 (ISSN-L)
- 1099-1611
- OpenAlex
- W2114455369
- Cited by
- 242
- References
- 4
- FWCI
- 9.10
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Development of CBT for chemotherapy‐related cognitive change: results of a waitlist control trial. https://app.cochat.ai/papers/10.1002/pon.1878
- The paper
- Ferguson, R. J., McDonald, B. C., Rocque, M. A., Furstenberg, C. T., Horrigan, S., Ahles, T. A., & Saykin, A. J. (2012). Development of CBT for chemotherapy‐related cognitive change: results of a waitlist control trial. Psycho-Oncology. https://doi.org/10.1002/pon.1878
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.